New Phase III study of nintedanib in people with systemic sclerosis and lung fibrosis
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news
Taking it personally, cutting-edge biotech snags $45 million
As Dr. Hal Dietz fielded offers to spin out his research from Johns Hopkins University into a venture-backed biotech company focused on fibrotic diseases, he turned to MPM Capital's Luke Evnin.
Evnin, a founder of MPM, is chairman of the Scleroderma Research Foundation, which had funded Dietz's fibrosis research work over the last seven or eight years with $1 million. It is a role that has given Evnin a front-row seat to the work done in academic labs aimed at skin-thickening and connective tissue… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 20, 2016 Category: Biotechnology Authors: Ron Leuty Source Type: news
Taking it personally, cutting-edge biotech snags $45 million
As Dr. Hal Dietz fielded offers to spin out his research from Johns Hopkins University into a venture-backed biotech company focused on fibrotic diseases, he turned to MPM Capital's Luke Evnin.
Evnin, a founder of MPM, is chairman of the Scleroderma Research Foundation, which had funded Dietz's fibrosis research work over the last seven or eight years with $1 million. It is a role that has given Evnin a front-row seat to the work done in academic labs aimed at skin-thickening and connective tissue… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 20, 2016 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Scleroderma: Condition sometimes mistaken for arthritis causes skin and organs to HARDEN
A WOMAN who is bravely battling a condition which causes her skin to harden and even affects the internal organs, has spoken out about her struggle. (Source: Daily Express - Health)
Source: Daily Express - Health - July 8, 2016 Category: Consumer Health News Source Type: news
Angiotensin-converting enzyme (ACE) inhibitors
ACE inhibitors treat a variety of conditions, such as high blood pressure, scleroderma and migraines. Find out more about this class of medication. (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - June 28, 2016 Category: Consumer Health News Source Type: news
Actemra may reduce scleroderma skin thickening
The interleukin-6 inhibitor tocilizumab (Actemra) substantially reduced skin thickening in patients with systemic sclerosis in the “proof-of concept” faSScinate trial, the results of which have now been published in the Lancet.
The mean change in the primary endpoint of a modified Rodnan skin... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 27, 2016 Category: Dermatology Source Type: news
Potential non-invasive screening biomarker for SSc-PAH
Serum asymmetric dimethylarginine may be an effective non-invasive screening biomarker for systemic sclerosis-related pulmonary arterial hypertension, study findings indicate. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Pulmonary hypertension Source Type: news
Angiotensin II receptor blockers
, sometimes called angiotensin II inhibitors, treat a variety of conditions, such as high blood pressure, heart failure and scleroderma. (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - June 13, 2016 Category: Consumer Health News Source Type: news
Female sex hormone clue to fighting serious immune disease
The results of a study showed for the first time a beneficial effect of estrogens in experimental models of skin fibrosis that are representative of the disease process in systemic sclerosis (SSc). These findings may explain the increased incidence of SSc in women after the menopause, the greater severity of SSc in men, and importantly open up the possibility of developing potential hormone therapies for this difficult-to-treat condition. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 10, 2016 Category: Science Source Type: news
Reduced RV functional reserve may explain poor SSc-PAH outcomes
Patients who develop pulmonary arterial hypertension as a consequence of systemic sclerosis have poorer right ventricular functional reserve than those with idiopathic disease, research published in Circulation shows. (Source: MedWire News)
Source: MedWire News - June 8, 2016 Category: Consumer Health News Tags: Pulmonary hypertension Source Type: news
June is Scleroderma Awareness Month
The campaign theme touches on the difficulty of the word and the gravity of scleroderma, a rare disease with no known cause or cure (Source: Disabled World)
Source: Disabled World - June 2, 2016 Category: Disability Tags: Skin Conditions Source Type: news
Sclerodermas suffer's joints are so stiff she has to lie in oil for three HOURS
Nicola Whitehill, 42, from Merseyside, suffers from scleroderma - a condition that results in hard, thickened areas of skin and sometimes problems with internal organs and blood vessels. (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2016 Category: Consumer Health News Source Type: news
No Benefit From Macitentan Seen in Systemic SclerosisNo Benefit From Macitentan Seen in Systemic Sclerosis
No differences in reduction of new digital ulcers occurred among groups receiving 3 mg macitentan, 10 mg macitentan, or placebo in two international, multicenter trials. Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 11, 2016 Category: Dermatology Tags: Rheumatology News Source Type: news
